Fig 1: Difference in Immune, TMB, and Pathway of DcR3 High/Low Group. a Immune cell abundance in DcR3 High/Low Group. b Difference of immune feature sets in DcR3 High/Low Group. c TMB score in DcR3 High/Low Group. d Enrichment pathway in DcR3 High group and Low group (e)
Fig 2: Correlation between DcR3 and riskScore group of DARS. a Heatmap of DcR3 and genes in IL-17 signaling pathway. b Correlation between DcR3 and genes. c Correlation between DcR3 and riskScore
Fig 3: Expression and Prognosis of DcR3 in CRC. a DcR2 mRNA expression in READ and COAD. b OS of DcR3 from TCGA, KM plotter c and DFS of DcR3 (TCGA). d Expression of DcR3 in different clinical feature stage. f IHC straning of DcR3 in normal and tumor tissue. e Expression of DcR3 protein in normal and tumor tissue
Fig 4: PCDHGA3 gene knockdown. (A) PCDHGA3 mRNA was detected in the FL-derived cell lines, FL18 and FL318. Knockdown of the PCDHGA3 gene was confirmed by (B) reverse transcription-quantitative polymerase chain reaction, (C) western blotting and (D) immunofluorescence. The siRNA, s31924, was selected for further analysis because it yielded the greatest PCDHGA3 mRNA inhibition ratio (55.9%) relative to untreated FL18 cells, original magnification ×100. (E) Cell proliferation was significantly suppressed in PCDHGA3 siRNA-treated FL18 cells at 72 h. (F) Coexpression of PCDHGA3 and TNFRSF6B was observed in the FL18 cell line by double immunofluorescence staining, original magnification ×200. *P<0.01; **P<0.001. PCDHG, protocadherin γ; FL, follicular lymphoma; siRNA, small interfering RNA; TNFRSF6B, tumor necrosis factor receptor superfamily member 6B; DAPI, 4,6-diamidino-2-phenylindole.
Fig 5: DcR3-Associated Risk Score (DARS) Model. a Lasso coefficient profiles of the 7 DcR3-Associated genes. b Survival time and status of High/Low Risk patients and expression of three genes in High/Low Risk group. c LASSO regression analysis was used to prevent the overfitting effects of the model. d The screened genes were brought into multivariate Cox regression analysis and constructed the DARS Model
Supplier Page from Abcam for Anti-DcR3 antibody [7G5]